Is Merrimack Pharmaceuticals Inc (MACK) Going to Burn These Hedge Funds?

Page 2 of 2

With the returns shown by Insider Monkey’s research, retail investors should always pay attention to hedge fund and insider trading sentiment, and Merrimack Pharmaceuticals Inc (NASDAQ:MACK) is no exception.

Click here to learn why you should track hedge funds

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
EXACT Sciences Corporation (NASDAQ:EXAS) 12 0 0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) 10 1 4
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) 11 0 1
Array Biopharma Inc (NASDAQ:ARRY) 20 0 0
Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) 3 0 1
Page 2 of 2